Ximedica Client Accelerate Diagnostics Receives FDA Clearance
Mar 01, 2017
Ximedica client Accelerate Diagnostics has been granted FDA clearance to market the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for identification and antibiotic susceptibility testing of pathogens directly from positive blood culture samples.
Accelerate Diagnostics came to Bridge Design, a Ximedica Company, with its novel and potentially life-saving diagnostic technology to design and engineer an elegant and highly functional enclosure and simplified consumable. Using its trademark multidisciplinary approach, Bridge’s industrial designers came up with an iconic visual design that proved compact and user-friendly for routine loading and unloading of samples. Bridge engineers then worked with Accelerate engineers to translate this vision into a cost-conscious solution focused on ease of use, manufacturability, and reliability.
The Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit was also honored with a gold medal in the Diagnostics Products and Systems category of the prestigious 2016 Medical Design Excellence Awards (MDEA).
To read the full press release, please visit the Accelerate Diagnostics website.